Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panzytrat 25000 in diabetes mellitus with exocrine pancreatic insufficiency
2015-005491-20Phase 4Completed
- Sponsor
- Allergan
- Start
- Mar 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of pancrelipase in exocrine pancreatic insufficiency (EPI), sponsored by Allergan. Started Mar 2016; status: completed.
02
Drugs
pancrelipase
03
Conditions
exocrine pancreatic insufficiency (EPI)
Beyond the preview
Go deeper on 2015-005491-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005491-20.